The Women’s leads world-first trial of potential new treatment for pre-eclampsia
The Royal Women's Hospital has launched the world's first clinical trial in pregnant women of a new therapy designed to target the biological pathway believed to drive pre-eclampsia.
Find out more-
International Women’s Day: our role in breaking down gender-based healthcare barriersThe Women’s CEO Professor Sue Matthews has spoken at a Victorian Comprehensive Cancer Centre (VCCC) Alliance event, addressing gender bias in Australian healthcare.
Learn more -
HPV vaccination rates boosting ‘health equity’ for girls and womenNew data shows that most Australian students are taking part in the National Vaccination Program for Human Papillomavirus (HPV), regardless of gender.
Learn more -
The Women’s celebrates IWDThe message at the heart of the Royal Women’s Hospitals’ International Women’s Day Breakfast was simple: we need to listen to the varied and powerful voices of women.
Learn more -
Endometriosis research a priority for the Women’sNine endometriosis projects are exploring non-invasive diagnosis options, supplement-based pain relief, the rollout of a digital fertility platform, and more.
Learn more -
The Women’s welcomes focus on sex and gender differences within the health systemCEO of the Royal Women’s Hospital, Professor Sue Matthews welcomes the release of the terms of reference for the National Women’s Health Advisory Council.
Learn more -
Researchers inspire students at the Women’s ‘Meet a Scientist’ eventHundreds of female students have participated in the Women’s annual ‘Meet a Scientist’ event, held on the eve of International Day of Women and Girls in Science.
Learn more